Zymergen Inc. (ZY) is an Industrial Specialties company listed on NASDAQ. There were no new wire items for ZY in the last 30 days. The most recent was published Oct 31, 2022.
Latest news
25 items- SECSEC Form 15-12G filed by Zymergen Inc.15-12G - Zymergen Inc. (0001645842) (Filer)
- SECSEC Form EFFECT filed by Zymergen Inc.EFFECT - Zymergen Inc. (0001645842) (Filer)
- 13D/GSEC Form SC 13G/A filed by Zymergen Inc. (Amendment)SC 13G/A - Zymergen Inc. (0001645842) (Subject)
- INSIDERSEC Form 4: Svf Excalibur (Cayman) Ltd disposed of 26,614,219 shares4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Flatley Jay T returned 144,789 shares to the company, closing all direct ownership in the company4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Chu Steven returned 50,000 shares to the company, closing all direct ownership in the company4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Peterson Sandra E returned 119,119 shares to the company, closing all direct ownership in the company4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Murdoch Travis returned 79,697 shares to the company, closing all direct ownership in the company4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Gorjanc Christine Marie returned 50,000 shares to the company, closing all direct ownership in the company4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4 filed by Sharma Rohit4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Ocko Matthew returned 7,366,635 shares to the company4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Singh Enakshi returned 462,241 shares to the company, closing all direct ownership in the company4 - Zymergen Inc. (0001645842) (Issuer)
- INSIDERSEC Form 4: Serber Zachariah returned 2,631,685 shares to the company, closing all direct ownership in the company4 - Zymergen Inc. (0001645842) (Issuer)
- SECSEC Form POS AM filed by Zymergen Inc.POS AM - Zymergen Inc. (0001645842) (Filer)
- SECSEC Form S-8 POS filed by Zymergen Inc.S-8 POS - Zymergen Inc. (0001645842) (Filer)
- SECSEC Form S-8 POS filed by Zymergen Inc.S-8 POS - Zymergen Inc. (0001645842) (Filer)
- NEWSZymergen Announced Further Reduction In Force That Is Expected To Result In The Termination Of About 110 Employees; Estimates It Will Incur Cash-Based Severance Costs Of About $7.9M Related To The October 2022 Reduction In Force- Reuters
- SECZymergen Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Costs Associated with Exit or Disposal Activities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits8-K - Zymergen Inc. (0001645842) (Filer)
- PRGinkgo Bioworks Completes Acquisition of ZymergenBOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE:DNA), the leading horizontal platform for cell programming, and Zymergen (NASDAQ:ZY) announced that Ginkgo has completed its previously announced acquisition of Zymergen. The acquisition is expected to significantly enhance Ginkgo's platform by integrating strong automation and software capabilities as well as a wealth of experience across diverse biological engineering approaches. "Today marks an important step in our long-term growth as we complete the Zymergen acquisition and welcome t
- SECSEC Form 25-NSE filed by Zymergen Inc.25-NSE - Zymergen Inc. (0001645842) (Subject)
- SECSEC Form 425 filed by Zymergen Inc.425 - Zymergen Inc. (0001645842) (Subject)
- SECZymergen Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Zymergen Inc. (0001645842) (Filer)
- SECSEC Form 425 filed by Zymergen Inc.425 - Zymergen Inc. (0001645842) (Subject)
- SECZymergen Inc. filed SEC Form 8-K: Other Events8-K - Zymergen Inc. (0001645842) (Filer)
- INSIDERSEC Form 4: Singh Enakshi sold $10,598 worth of shares (3,786 units at $2.80), decreasing direct ownership by 0.81% to 462,241 units4 - Zymergen Inc. (0001645842) (Issuer)
ZY FAQ
8 questionsWhat does Zymergen Inc. do?
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.What is the latest news on ZY?
Quantisnow has not tracked any new filings, ratings or press releases for ZY in the last 30 days. The most recent wire item was published on October 31, 2022.Where does ZY stock trade?
Zymergen Inc. (ZY) is listed on NASDAQ.What sector and industry is ZY in?
Zymergen Inc. operates in the Industrials sector, Industrial Specialties industry.When did Zymergen Inc. go public?
Zymergen Inc. (ZY) completed its IPO in 2021.What are analysts saying about ZY?
Across the last 8 analyst actions on Zymergen Inc., there was 1 upgrade and 5 downgrades. The most recent action was from Cowen: Market Perform on 2022-03-02. Recent price targets range from $6.50 to $13.00.What companies are similar to ZY?
Notable peers in the same industry include ALGN (Align Technology Inc.), ZBH (Zimmer Biomet Holdings Inc.), STE (STERIS plc (Ireland)), EW (Edwards Lifesciences Corporation), ISRG (Intuitive Surgical Inc.). Compare ZY side-by-side with any of them on Quantisnow.How can I track ZY on Quantisnow?
Quantisnow aggregates Zymergen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZY to receive live email and push alerts on every new disclosure.